In addition, mast cells in RA synovial tissue abundantly express CXCR3; this may maintain the synovial inflammatory environment by binding CXCL9 and CXCL10 and producing mediators, including histamine, proteases, arachidonic acid metabolites, and cytokines (65). This evidence concerns the gene CXCR3 and rheumatoid arthritis.